1 |
Montgomery EJ, Xing E, Campbell MJ, Li PK, Blachly JS, Tsung A, Coss CC. Constitutively Active Androgen Receptor in Hepatocellular Carcinoma. Int J Mol Sci 2022;23. [PMID: 36430245 DOI: 10.3390/ijms232213768] [Reference Citation Analysis]
|
2 |
Lee H, Lee I, Park S, Jung M, Yang SG, Kwon T, Lee D. Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network Pharmacology. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-14. [DOI: 10.1155/2022/5765233] [Reference Citation Analysis]
|
3 |
Vallejo-ardila DL, De Bastiani MA, Salazar DA. Regulators of Genetic Risk for the Progression of Non-alcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Reconstruction of Transcriptional Network and Signature-Based Metabolic Profiling. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_40] [Reference Citation Analysis]
|
4 |
Moon Y, Korcsmáros T, Nagappan A, Ray N. MicroRNA target-based network predicts androgen receptor-linked mycotoxin stress. Ecotoxicol Environ Saf 2021;230:113130. [PMID: 34968797 DOI: 10.1016/j.ecoenv.2021.113130] [Reference Citation Analysis]
|
5 |
Di Vincenzo A, Russo L, Doroldi CG, Vettor R, Rossato M. Sex hormones abnormalities in non-alcoholic fatty liver disease: pathophysiological and clinical implications. Exploration of Medicine. [DOI: 10.37349/emed.2021.00049] [Reference Citation Analysis]
|